Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study: testing for joint substance in blood might improve diagnosis of osteoarthritis

28.02.2005


Measuring a biological chemical called hyaluronan found naturally in joints and the fluid that lubricates cartilage might enable doctors to diagnose osteoarthritis of the knee and hip earlier or more accurately, a new study concludes. Improving diagnosis of the painful inflammatory disorder should become increasingly important as baby boomer age, doctors say.



The research, conducted at the University of North Carolina at Chapel Hill and in Johnston County, N.C., revealed that levels of the chemical, also known as HA, in blood samples corresponded with how advanced osteoarthritis was in a group of rural patients, both blacks and whites. "Our study shows statistically significant differences in average levels of serum hyaluronan (HA) between individuals with osteoarthritis of the knee as shown on X rays and those without knee or hip osteoarthritis," said study director Dr. Joanne M. Jordan. "Serum HA levels not only were associated with the presence of osteoarthritis but also showed a trend of increasing values as severity of the disease increased."

Jordan is associate professor of medicine and orthopaedics at the UNC School of Medicine. Also associate director of the Thurston Arthritis Research Center, she is principal investigator for the long-term Johnston County Osteoarthritis Project. That investigation is the largest of its kind ever done and involves more than 3,000 volunteers whose health and experiences with arthritis doctors follow and analyze. A report on the findings appears in the January issue of Arthritis & Rheumatism, a journal published by the American College of Rheumatology.


Besides Jordan, UNC schools of medicine and public health authors are Dr. Alan L. Elliott, a rheumatology fellow; Dr. Jordan Renner, professor of radiology and allied health sciences; and Anca D. Dragomir and Gheorghe Luta, doctoral students in epidemiology and biostatistics, respectively. Dr. Virginia B. Kraus, associate professor of medicine, and Thomas Stabler, both at Duke University, Dr. Charles D. Helmick of the Centers for Disease Control and Prevention and Dr. Marc C. Hochberg of the University of Maryland also participated in the study.

Hyaluronan is produced by cells of what is called the extracellular matrix, Jordan said. It is thought to contribute to lubricating joints, a process without which walking and running would be unbearably painful. Earlier work suggested HA might serve as a sign, or biomarker, of osteoarthritis. "Our study is unique in that it consisted of a large, ethically diverse, population-based sample of African Americans and Caucasians and incorporates five definitions of osteoarthritis as shown on X rays," she said. "This was the first study of hyaluronan and osteoarthritis to include African Americans and to consider how other health problems commonly occurring with osteoarthritis might confound the relationship between serum HA and osteoarthritis."

The researchers studied 753 subjects, including 455 with osteoarthritis in their knees. Volunteers ranged in age from about 51 to 72 and averaged almost 62. About 39 percent suffered from high blood pressure, the most common other illness. The least common was cancer. Average serum HA levels correlated with age, Jordan said. Whites and men showed higher levels than blacks and women, which could reflect genetic or physiologic factors. Such sex and racial differences would need to be taken into account when determining the usefulness of HA and other potential biomarker testing.

Medical scientists have known for the past decade that levels of an important protein known as COMP were higher in cartilage, ligaments, tendons and joint lubricating fluid of whites with osteoarthritis than in whites without the painful, degenerative illness, Jordan said. In 2003, she and her UNC colleagues showed for the first time that the same thing is true in blacks. They also found average levels of the protein to be higher in blacks -- both patients and others -- than in whites and higher among white men than among white women. "These discoveries are likely to be important in the search for better ways to predict who is at strong risk of developing osteoarthritis, who has it already and whose illness is most likely to progress," Jordan said.

Osteoarthritis, the most common form of arthritis, afflicts almost a million North Carolinians and more than 21 million people nationally, including many adults over age 65, the physician said. Some estimates suggest that as many as 70 million Americans will suffer from some form of arthritis within the next 20 years as baby boomers age.

Support for the research came from the CDC, the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Arthritis Foundation.

David Williamson | EurekAlert!
Further information:
http://www.unc.edu

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>